Grinta gets funding from Beltone & Raed Ventures, acquires Citi Clinic

Grinta announced its acquisition of Citi Clinic, one of the most renowned and successful primary healthcare service chains in Egypt. At the same time, Grinta managed to raise an undisclosed amount of strategic investment from Beltone Venture Capital and Raed Ventures.

The acquisition of Citi Clinic provides Grinta with access to over 150,000 patients, establishing its presence in the care sector and reinforcing its commitment to patient-centered healthcare

This move is part of a global trend where B2B pharmaceutical distributors are transitioning into B2C operations. In the United States, companies such as McKesson and Walgreens have successfully adopted similar strategies — leveraging their supply chain expertise to deliver comprehensive healthcare solutions directly to consumers. Grinta plans to replicate this success, expanding its offline and online healthcare services across Egypt and the East Africa region.

As part of this transformation, Grinta has exited its B2B retail pharmaceutical distribution business in Egypt to focus entirely on the care sector.

In addition, the company is extending its footprint in East Africa, beyond Tanzania, by exporting and forming partnerships with Egyptian pharmaceutical manufacturers. Further, Grinta is building a pharmacy chain in Tanzania through a buy-and-build strategy, further strengthening its retail presence in the region.